Clinical Trial Update: Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation [Phase 2]

View source ↗

Summary

Phase 2 trial update for IPA targeting and non-inherited maternal antigen matching in haplo-cord transplantation for hematologic malignancies; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Hematologic Malignancies | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-10-09